前沿热点-热点资讯
Antibody Responses and Clinical Outcomes in Adults Hospitalized with Severe COVID-19: A Post hoc Analysis of LOTUS China Trial
icon 2020年08月26日
icon 曹彬丨王健伟
icon COVID-19
icon 557

2020.8.26 CID antibody response-LOTUS China trial_页面_01.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_02.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_03.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_04.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_05.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_06.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_07.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_08.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_09.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_10.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_11.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_12.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_13.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_14.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_15.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_16.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_17.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_18.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_19.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_20.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_21.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_22.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_23.jpg

2020.8.26 CID antibody response-LOTUS China trial_页面_24.jpg

请在验证后发表评论
热门推荐